ReviewFrontiers in pharmacology2020

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms.

Daiji Kawanami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.